Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06887543 · ClinicalTrials.gov registry record · NA
The Impact of Time Restricted Eating on Type 2 Diabetes
A NA study, sponsored by Rockefeller University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT06887543 is a NA study that was terminated before completion, run by Rockefeller University. The registered enrollment target is 2 participants.
The verdict
NCT06887543, a NA study, was terminated before completion, sponsored by Rockefeller University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Time-restricted feeding limits caloric intake to active daytime hours with fasting for 14 to 16 hours. It has shown great promise as a novel intervention for stabilizing blood glucose, reducing weight, and improving cardiovascular disease outcomes. However, this approach has not been tested on people with diabetes, a group that would benefit from improved blood glucose and weight loss. The impact of Time-Restricted Eating on Type 2 Diabetes Study (EaT2D Study) is a randomized six-day weight stable crossover feeding study in the Day Patient/Outpatient unit of The Rockefeller Hospital investigating how the time of day that meals are eaten affects weight, blood sugar and blood pressure. The investigators will compare an early time-restricted eating intervention (80% of calories consumed before 2 pm) to a usual feeding pattern (50% of calories consumed after 4 pm) among 10 persons with type 2 diabetes to determine effects on blood sugar and small molecules found in the blood. Studies have shown benefits of eating during active periods (mornings and early afternoon) for metabolic health (blood sugar, body weight) compared to eating during inactive periods (evening and bedtime). Eating earlier in the day may lead to reduced sugar stores, burning fat for energy, and decreased inflammation when compared to eating later in the day. The investigators will compare the effects of eating earlier during the day for six days versus later in the day for six days, on blood sugar, blood pressure, blood ketones, and other measures of metabolic health in diabetic participants. Studies in animals supports these benefits.
Interventions
- OTHER Time restricted eating
- OTHER Meal timing
- OTHER Usual feeding pattern.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2025-05-29 |
| Est. Completion | 2025-08-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06887543
The ClinicalTrials.gov registry entry for NCT06887543 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Time restricted eating is the first listed.
NCT06887543 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06887543 about?
NCT06887543 is a clinical study titled "The Impact of Time Restricted Eating on Type 2 Diabetes". Time-restricted feeding limits caloric intake to active daytime hours with fasting for 14 to 16 hours. It has shown great promise as a novel intervention for stabilizing blood glucose, reducing weight, and improving cardiovascular disease outcomes. However, this approach has not been tested on peopl...
What is the current status of trial NCT06887543?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2025-05-29. Estimated completion is 2025-08-04.
What interventions are being tested in trial NCT06887543?
The interventions under investigation include: Time restricted eating (OTHER), Meal timing (OTHER), Usual feeding pattern. (OTHER).
Who is sponsoring clinical trial NCT06887543?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.